Moderna announced that Jorge Gomez will join Moderna as Chief Financial Officer, effective Monday, May 9, 2022. He will serve on Moderna's Executive Committee and report to Chief Executive Officer, Stéphane Bancel.

"I am pleased to welcome Jorge to Moderna as our Chief Financial Officer and as a member of the Executive Committee," said Bancel. "As we grow and scale the company globally, Jorge's experience leading the financial functions of multinational healthcare companies will be an asset to our team. Jorge's passion for sustainability and ESG aligns closely with Moderna's vision to make corporate responsibility a critical part of who we are and what we do. I look forward to working with Jorge as we continue to deliver on our strategic priorities to ultimately impact human health with mRNA medicines."

Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019. At Dentsply Sirona, he was responsible for leading the global finance organization, including strategic finance, FP&A, Accounting, Treasury, Tax, Corporate Audit and Investor Relations, and the Information Technology function. In addition, Gomez was responsible for leading Dentsply Sirona's sustainability and ESG program.

"It is a privilege for me to join an organization that is focused on developing transformative medicines to address major public healthcare challenges worldwide," said Gomez. "I look forward to working with the team on this great mission."

Gomez received his Master of Business Administration from the University of Hartford and his Bachelor of Science in electrical engineering from the National University of Colombia. Gomez serves on the Board of Directors for Xylem and Pear Therapeutics.